- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 10 - Drivers of Cost in Cardiometabolic Management
During this segment, the panelists discuss the highest drivers of cost when managing cardiometabolic disease. Michael Weber, MD, explains that adverse events cause costs to rise dramatically and Kenneth L. Schaecher, MD, FACP, CPC, clarifies the fact that from a managed care standpoint, the greatest proportion of dollars are spent on inpatient services.
David Calabrese, RPh, MHP, claims that 70% of the dollars spent today are used to manage factors associated with diabetes, including cardiovascular comorbidities, and explains that the dollars are used to try to prevent other negative sequalae from occurring down the road.
Additionally, the panelists explain that the topic of the costs associated with cardiometabolic management is controversial. Dr Schaecher explains that preventing cardiometabolic events can be more expensive than treating an event on a firsthand basis due to the costs of drugs for the treatment of long-term conditions, or risk factors.
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
